Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (15)

Company Market Cap Price
TMO Thermo Fisher Scientific Inc.
Thermo Fisher offers bioprocessing equipment, including single-use bioreactors for scalable biomanufacturing.
$214.25B
$567.41
+2.01%
DHR Danaher Corporation
Danaher directly manufactures bioprocessing equipment like the X-platform bioreactor for biopharmaceutical production.
$154.22B
$215.38
+0.15%
IR Ingersoll Rand Inc.
Bioprocessing Equipment covers systems used in biopharmaceutical manufacturing, aligning with ILC Dover containment capabilities.
$30.34B
$76.33
-3.05%
SOLV Solventum Corporation
Harvest RC family represents bioprocessing equipment used in manufacturing biologics.
$11.94B
$69.04
-0.35%
DCI Donaldson Company, Inc.
Bioprocessing equipment alignment within Life Sciences, including manufacturing-scale applications.
$9.82B
$84.19
+0.60%
BIO Bio-Rad Laboratories, Inc.
Bio-Rad manufactures bioprocessing equipment used in upstream/downstream processing for biopharmaceutical manufacturing.
$8.65B
$320.03
+5.06%
RGEN Repligen Corporation
Repligen's core business is manufacturing bioprocessing equipment for upstream and downstream biologics production (e.g., ATF systems, mixers, packed columns).
$8.37B
$149.07
+3.11%
AVTR Avantor, Inc.
Bioprocessing Equipment is a core product category representing Avantor's process hardware for biopharma production.
$8.06B
$11.83
+7.06%
SXI Standex International Corporation
Bioprocessing equipment manufacturing through Nascent Technology Manufacturing and Custom Biogenic Systems.
$2.82B
$234.05
-1.95%
ATS ATS Corporation
ATS supplies Bioprocessing Equipment for Life Sciences production lines (radiopharma workflows, etc.).
$2.66B
$27.50
+3.27%
BLFS BioLife Solutions, Inc.
BioLife's core offering is bioprocessing equipment and automation for CGT manufacturing (Cell Processing platform) and related devices.
$1.33B
$27.91
+3.75%
HUMA Humacyte, Inc.
Bioprocessing Equipment aligns with the bioreactor manufacturing system underpinning Humacyte's platform.
$259.05M
$1.66
+2.47%
DYAI Dyadic International, Inc.
Operations involve bioprocessing equipment concepts and upstream/downstream processing hardware related to protein production.
$34.00M
$1.14
-2.56%
HBIO Harvard Bioscience, Inc.
HBIO's BTX bioproduction platforms and cGMP-compatible systems are bioprocessing equipment used in upstream and downstream pharmaceutical manufacturing.
$22.84M
$0.51
-18.40%
SCND Scientific Industries, Inc.
Bioprocessing Equipment – direct manufacturing of bioprocessing hardware used for biopharmaceutical production.
$7.74M
$0.67

Loading company comparison...

Loading research report...

AVTR Avantor, Inc.

Avantor Launches Sterile Sampling Suite to Strengthen Bioprocessing Offerings

Oct 31, 2025
AVTR Avantor, Inc.

Avantor Reports Q3 2025 Results: Revenue Declines, Losses, and Guidance Cut

Oct 30, 2025
BIO Bio-Rad Laboratories, Inc.

Bio‑Rad Reports Q3 2025 Results: Revenue Up 0.5%, Net Loss Due to Fair‑Value Adjustment

Oct 30, 2025
IR Ingersoll Rand Inc.

Ingersoll Rand Reports Q3 2025 Results, Revises Full-Year Adjusted EBITDA Guidance

Oct 30, 2025
TMO Thermo Fisher Scientific Inc.

Thermo Fisher to Acquire Clario Holdings for $8.875 Billion in Cash

Oct 29, 2025
AVTR Avantor, Inc.

Avantor Partners with p‑Chip to Launch Smart Consumables with Embedded Digital Traceability

Oct 23, 2025
TMO Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Launches First Orbitrap Mass Detector for Environmental and Food Safety Testing

Oct 23, 2025
TMO Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Reports Strong Q3 2025 Earnings, Raises 2025 Guidance

Oct 22, 2025
DHR Danaher Corporation

Danaher Reports Third Quarter 2025 Results, Exceeds Expectations

Oct 21, 2025
AVTR Avantor, Inc.

Avantor Announces Strategic Partnership with BlueWhale Bio to Accelerate CAR‑T Manufacturing

Oct 15, 2025
AVTR Avantor, Inc.

Avantor Announces Board Chairman Transition

Oct 13, 2025
TMO Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Introduces New Molecular Microscope Diagnostic System for Lung Transplant Rejection

Oct 10, 2025
DHR Danaher Corporation

Danaher's Leica Biosystems Unveils New AI-Powered Digital Pathology Solutions

Oct 01, 2025
HBIO Harvard Bioscience, Inc.

Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States

Sep 16, 2025
DHR Danaher Corporation

Beckman Coulter Diagnostics Launches Industry-First Fully Automated BD-Tau Immunoassay Test for Neurodegenerative Research

Sep 10, 2025
DHR Danaher Corporation

Genedata Enhances Biopharma R&D Efficiency with New Unified Sample Management Solution

Aug 28, 2025
DHR Danaher Corporation

Genedata Selector® Update Powers GMP-Compliant NGS in Biopharma Manufacturing

Aug 12, 2025
HBIO Harvard Bioscience, Inc.

Harvard Bioscience Reports Q2 2025 Results, Secures Critical Credit Agreement Amendment Waiving Defaults

Aug 11, 2025
IR Ingersoll Rand Inc.

Ingersoll Rand Expands Life Sciences Portfolio with Acquisition of Dave Barry Plastics

Aug 04, 2025
DHR Danaher Corporation

Danaher Appoints Jonathan Leiken as Senior Vice President and General Counsel

Jul 31, 2025
IR Ingersoll Rand Inc.

Ingersoll Rand Reports Record Q2 2025 Orders, Revenues, and Adjusted EBITDA

Jul 31, 2025
DHR Danaher Corporation

Aldevron, a Danaher Company, Opens New Innovation Center in Waltham, MA

Jul 30, 2025
DHR Danaher Corporation

Danaher Exceeds Q2 2025 Expectations, Raises Full-Year Profit Outlook on Robust Bioprocessing Growth

Jul 22, 2025
HBIO Harvard Bioscience, Inc.

Harvard Bioscience Announces CEO Succession Plan with John Duke, Appoints Two New Independent Directors

Jul 17, 2025
IR Ingersoll Rand Inc.

Ingersoll Rand Appoints Aurobind Satpathy to Board of Directors

Jul 15, 2025
IR Ingersoll Rand Inc.

Ingersoll Rand Acquires TMIC/Adicomp for €160 Million, Boosts Compressor and RNG Capabilities

Jul 01, 2025
DHR Danaher Corporation

Danaher Appoints Martin Stumpe as Chief Technology and AI Officer, Effective October 1, 2025

Jun 27, 2025
DHR Danaher Corporation

Danaher Releases 2025 Sustainability Report, Highlighting Innovation and Environmental Commitments

Jun 10, 2025
IR Ingersoll Rand Inc.

Ingersoll Rand Acquires Lead Fluid, Expands Life Sciences Presence in China

Jun 03, 2025
DHR Danaher Corporation

SCIEX Launches ZenoTOF 8600 System and Enhanced OS Software, Setting New Standards in Mass Quantitation and AI-Driven Data Processing

Jun 02, 2025
HBIO Harvard Bioscience, Inc.

Harvard Bioscience Appoints John Duke to Board of Directors, Katherine Eade Named Lead Independent Director

Jun 02, 2025
DHR Danaher Corporation

Danaher Partners with AstraZeneca to Scale Precision Medicine Diagnostics with AI-Powered Tools

May 30, 2025
DHR Danaher Corporation

Aldevron Manufactures World's First mRNA-Based Personalized CRISPR Therapy

May 15, 2025
HBIO Harvard Bioscience, Inc.

Harvard Bioscience Reports $48 Million Goodwill Impairment in Q1 2025, Leading to Significant Net Loss

May 12, 2025
IR Ingersoll Rand Inc.

Ingersoll Rand Reports Q1 2025 Results, Posts Revenue Growth and Record Free Cash Flow

May 01, 2025
DHR Danaher Corporation

Aldevron and Kytopen Collaborate to Expedite CRISPR-Mediated Cell Therapy Manufacturing

Apr 29, 2025
DHR Danaher Corporation

Danaher Anticipates $350 Million Tariff Impact, Outlines Mitigation Strategy

Apr 24, 2025
DHR Danaher Corporation

Danaher Exceeds Q1 2025 Expectations with Strong Bioprocessing Momentum and Maintained Full-Year Guidance

Apr 22, 2025
IR Ingersoll Rand Inc.

Ingersoll Rand Acquires G & D Chillers and Advanced Gas Technologies, Enhancing Air Treatment Portfolio

Apr 15, 2025
HBIO Harvard Bioscience, Inc.

Harvard Bioscience Announces CFO Transition, Appoints Mark Frost as Interim CFO

Apr 10, 2025
DHR Danaher Corporation

Danaher Subsidiary Cepheid Partners with Oxford Nanopore to Advance Infectious Disease Sequencing

Apr 09, 2025
IR Ingersoll Rand Inc.

TRC Capital Amends Mini-Tender Offer for Ingersoll Rand, Lowers Price to $65.25 Per Share

Apr 09, 2025
IR Ingersoll Rand Inc.

Ingersoll Rand Appoints Michelle Swanenburg to Board of Directors

Apr 03, 2025
IR Ingersoll Rand Inc.

Ingersoll Rand Recommends Rejection of TRC Capital's Unsolicited Mini-Tender Offer

Mar 31, 2025
IR Ingersoll Rand Inc.

Ingersoll Rand Board Member Julie Schertell Resigns from Key Committees

Mar 28, 2025
HBIO Harvard Bioscience, Inc.

Harvard Bioscience Reports Continued Revenue Decline for Q4 and Full-Year 2024, Provides Lower Q1 2025 Guidance

Mar 12, 2025
DHR Danaher Corporation

Beckman Coulter Diagnostics Receives FDA Clearance for DxC 500i Clinical Analyzer

Mar 10, 2025
HBIO Harvard Bioscience, Inc.

Harvard Bioscience Showcases New Preclinical and Organoid Solutions, Announces NIH Adoption of Mesh MEA System

Feb 24, 2025
DHR Danaher Corporation

Danaher Increases Quarterly Cash Dividend by 18.5%

Feb 20, 2025
DHR Danaher Corporation

Danaher Leads Global Molecular Infectious Disease Testing Market Amidst Strong Growth Projections

Feb 13, 2025

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks